The Latest Gout Research at a Glance
In this episode of the Rheumatology Advisor ACR 2021 podcast series, Ada Kumar, MD, and Suneet Grewal, MD, discuss some of the important and clinically meaningful research presented at the meeting.
Home
Safety of SARS-CoV-2 Vaccines Assessed in Patients With Inflammatory and Noninflammatory Rheumatic and Musculoskeletal Diseases
Using data from the COVAX physician-reported registry, researchers studied the safety of SARS-CoV-2 vaccines in patients with inflammatory/autoimmune rheumatic and musculoskeletal diseases.
Horizon Seeks Approval of Pegloticase Plus Methotrexate for Uncontrolled Gout
The sBLA submission is supported by data from the phase 4 MIRROR trial.
Mycophenolate Mofetil and Azathioprine Linked to Low Malignancy in Patients With Fibrotic ILD
Are patients with fibrotic interstitial lung disease at risk of malignancy when treated with the immunomodulatory drugs MMF and AZA?
FDA Warns Against Using At-Home COVID-19 Test Swabs in the Throat
Swabs that come with at-home rapid antigen COVID-19 tests should be used in the nose and not the throat, the U.S. Food and Drug Administration warns.
Novel Patient-Reported Outcome Tool Assesses Fatigue in Patients With Systemic Lupus Erythematosus
Researchers studied the implementation of a new patient-reported outcome instrument to measure and manage fatigue in patients with systemic lupus erythematosus.
Bisphosphonates Reduce Incidence of Hip Fractures in Patients With Osteoporosis, Osteopenia
Researchers investigated whether hip fractures could be prevented with bisphosphonates in people with osteoporosis or osteopenia.
Novel Immunomodulator Gets Orphan Drug Status for Sarcoidosis
Results from a phase 1/2 showed that ATYR1923 was safe and well tolerated.
Hospitals Are Rationing COVID-19 Pills, Infusions as Cases Rise
To deal with supply shortages, health care providers are developing algorithms to determine who gets treatment.
COVID-19 Vaccines Significantly Reduce MIS-C Risk in Adolescents
COVID-19 mRNA vaccination is associated with a lower incidence of multisystem inflammatory syndrome in children in adolescents.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pediatric Rheumatology
Loading... 
Loading...